You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
Kedrion Biosc - Front Image

news

  1. 26-03-2020

    Annual Results 2019

    Kedrion reaches a record high turnover of EUR 808.2 million and raises its REPORTED EBITDA to EUR 101.3 million

    read more 
  2. 16-10-2019

    FSI SGR enters Kedrion share capital

    The company continues with its growth and development strategy

    read more 
  3. 13-08-2019

    FIRST HALF RESULTS 2019

    Kedrion increased its turnover by 30.8% reaching Euro 364.0 million

    read more 

Pages

For more information please contact: investor@kedrion.com